I agree that this site is using cookies. You can find further informations here.
X
Narcisi, Alessandra
169  results:
Search for persons X
?
1

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for m..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
Frontiers in Immunology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Practical Use of Upadacitinib in Patients with Severe Atopi..:

Ibba, Luciano ; Gargiulo, Luigi ; Vignoli, Carlo...
Clinical, Cosmetic and Investigational Dermatology.  17 (2024)  - p. 593-604 , 2024
Link: https://doi.org/10.2147/..
 
?
3

Effectiveness and Safety of Biological Therapies in Very Se..:

Fiorillo, Giovanni ; Ibba, Luciano ; Gargiulo, Luigi...
Journal of Personalized Medicine.  14 (2024)  2 - p. 186 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Effectiveness of dupilumab in tralokinumab‐resistant patien..:

Tavoletti, Gianluca ; Chiei‐Gallo, Alessandra ; Gargiulo, Luigi...
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
5

Tildrakizumab: the value of a personalized and flexible app..:

Dapavo, Paolo ; Burlando, Martina ; Guarneri, Claudio...
Expert Opinion on Biological Therapy.  24 (2024)  3 - p. 133-138 , 2024
Link: https://doi.org/10.1080/..
 
?
6

Drug Survival of Upadacitinib and Predicting Factors of Dis..:

Pezzolo, Elena ; Ortoncelli, Michela ; Ferrucci, Silvia Mariel...
Journal of Clinical Medicine.  13 (2024)  2 - p. 553 , 2024
Link: https://doi.org/10.3390/..
 
?
7

Long-Term Effectiveness and Safety of Ixekizumab for the Tr..:

Valenti, Mario ; Gargiulo, Luigi ; Ibba, Luciano...
Dermatology and Therapy.  14 (2024)  6 - p. 1649-1657 , 2024
Link: https://doi.org/10.1007/..
 
?
8

Clinical outcomes and management of JAK inhibitor-associate..:

Avallone, Gianluca ; Mastorino, Luca ; Tavoletti, Gianluca...
Journal of the American Academy of Dermatology.  90 (2024)  5 - p. 1031-1034 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Effectiveness, Tolerability, and Drug Survival of Risankizu..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
Journal of Clinical Medicine.  13 (2024)  2 - p. 495 , 2024
Link: https://doi.org/10.3390/..
 
?
10

Autoreactivity to self-antigens LL37 and ADAMTSL5 influence..:

Favaro, Rebecca ; Facheris, Paola ; Formai, Alessandra...
Journal of Autoimmunity.  147 (2024)  - p. 103244 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Management of Patients Affected by Moderate-to-Severe Atopi..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
Dermatology and Therapy.  14 (2024)  4 - p. 919-932 , 2024
Link: https://doi.org/10.1007/..
 
?
12

Successful use of tralokinumab for the treatment of atopic ..:

Paolino, Giovanni ; Narcisi, Alessandra ; Carugno, Andrea...
Journal of Dermatological Treatment.  35 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
13

A Multidisciplinary Approach Is Beneficial in Atopic Dermat..:

Amerio, Paolo ; Ferrucci, Silvia Mariel ; Galluzzo, Marco...
Dermatology and Therapy.  14 (2024)  6 - p. 1443-1455 , 2024
Link: https://doi.org/10.1007/..
 
?
14

Effectiveness of ixekizumab for the treatment of moderate‐t..:

Valenti, Mario ; Gargiulo, Luigi ; Ibba, Luciano...
The Journal of Dermatology.  51 (2024)  6 - p. 839-843 , 2024
Link: https://doi.org/10.1111/..
 
?
15

Upadacitinib 30 mg for the optimal management of moderate-t..:

Gargiulo, Luigi ; Ibba, Luciano ; Bianco, Matteo...
Journal of Dermatological Treatment.  35 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
1-15